Astellas Pharma | 4503 - Pre Tax Profit

Stock Price
1,705.50
Daily Change
-18.50 -1.07%
Monthly
3.43%
Yearly
-4.77%
Q3 Forecast
1,683.14

Astellas Pharma reported JPY90.42B in Pre-Tax Profit for its fiscal quarter ending in June of 2025.



Financials
Stock Price JPY
Assets JPY 3335.83B
Cash and Equivalent JPY 188.37B
Cost of Sales JPY 94.83B
Current Assets JPY 1293.33B
Current Liabilities JPY 1107.94B
Debt JPY 831.43B
Dividend Yield 5.22
EBIT JPY 92.54B
EBITDA JPY 140.35B
Employees 14.75K
EPS Earnings Per Share JPY 38.22
Equity Capital and Reserves JPY 1481.79B
Gross Profit on Sales JPY 410.97B
Interest Expense on Debt JPY 3.91B
Interest Income JPY 4.12B
Loan Capital JPY 558.08B
Market Capitalization JPY 3086.15B
Net Income JPY 68.42B
Operating Expenses JPY 413.25B
Operating Profit JPY 92.54B
Ordinary Share Capital JPY 1.79B
PE Price to Earnings JPY 9.35
Pre-Tax Profit JPY 90.42B
Sales Revenues JPY 505.79B
Selling and Administration Expenses JPY 197B
Stock JPY 297.26B
Trade Creditors JPY 165.89B
Trade Debtors JPY 699.51B

Pre Tax Profit Change Date
Astellas Pharma JPY 90.42B 29.86B Jun/2025
Chugai Pharma JPY 136B 172M Jun/2025
Daiichi Sankyo JPY 105.44B 24.81B Jun/2025
Eisai JPY 22.4B 22.43B Jun/2025
Kyowa Hakko Kirin JPY 14.12B 6.26B Jun/2025
M3 JPY 19.68B 7.41B Jun/2025
Otsuka Holdings JPY 112.98B 391M Jun/2025
Shionogi JPY 46.33B 1.46B Jun/2025
Sumitomo Dainippon JPY 11.93B 18.35B Jun/2025
Takeda JPY 150.63B 257.93B Jun/2025
Terumo JPY 55.26B 32.51B Jun/2025